Weekly Roundup: November 15-19

POLL: Do you believe stem cell research is ethical?

Diagnosing Scarring and Nonscarring Hair Loss

In his presentation at the 2021 Fall Clinical Dermatology Conference for PAs & NPs, Matt L. Leavitt, DO, FAOCD, FISHRS, highlighted the methods to diagnose scarring and nonscarring alopecias.

Topical JAK Inhibitor May Treat Vitiligo

Ruxolitinib meets primary and secondary endpoints in phase 3 TRuE-V clinical trial program.

Pairing the Right Psoriasis Drug with the Right Patient

In a video for Dermatology Times®, Mark Lebwohl, MD, details how to match patients with the right psoriasis treatment for their specific needs.

The Latest in Scar Treatment

In this exclusive video interview with Dermatology Times®, Michael Gold, MD, tells us about his session at the New Frontiers in Cosmetic Medicine and Medical Dermatology Symposium.

JAK Inhibitors Could Fill AD, Vitiligo, and AA Treatment Gaps

The potential of JAK inhibitors and other emerging medications could answer demand for more treatment options for these challenging skin conditions.

Update in Acne for Lasers

In this exclusive interview with Dermatology Times®, David Goldberg, MD, JD, explains why lasers are a treatment option in acne and the latest advancements in the field.

Update on Actinic Keratosis Causes and Care Plans

Brian Berman, MD, PhD, maps the root causes, prevention strategies, and latest treatments for this widespread precancer at 2021 Fall Clinical Dermatology Conference for PAs & NPs.

Dealing With Difficult Patients

Experts discuss their tips for dealing with difficult patients, including those who refuse to pay, badmouth colleagues, and even cause a scene in the waiting room.

The Latest in Photoprotection for Melanoma

Darrel S. Rigel, MD, highlights updates in photoprotection, sunscreen SPF levels, and oxybenzone.

New Approaches in Rosacea Therapy

Neal Bhatia, MD, highlights new approaches in rosacea therapy in his session at the Fall Clinical Dermatology Conference for PAs & NPs.

The Mainstream Patient: November 15

This week’s edition of The Mainstream Patient features stories about hidradentitis suppurativa, how to get rid of blackheads and more!

Combination Approaches Drive Cosmeceutical Regimens

Natural skincare ingredients are always trending, said Patricia K. Farris, MD, hear what she had to say about using these in combination with other regimens.

How an Honest Mistake Can Lead to Fraud

In this month's Legal Eagle column, David J. Goldberg, MD, JD, discusses coding and billing in physician practices.

Sidestep Traps That Lead to Misdiagnosis

Dermatologist urges colleagues to take mindful measures to avoid errors.

Cleaning Up Cleanser Misinformation

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, explains misinformation surrounding skin and hair cleansing.

Is Your Practice’s Retirement Plan at Risk?

Mandell is an attorney and founder of the wealth management firm OJM Group in Cincinnati, Ohio. Braunscheidel is a wealth adviser at OJM Group.

Quality of Life and Acne: How is it Health Related?

This study aimed to examined morbidity associated with truncal acne.

Seemal Desai, MD: Advancements in Vitiligo Therapies

New therapies are breaking ground in the world of vitiligo research, which Seemal Desai, MD, believes will result in FDA approvals in the coming years.

A Deep Dive on Instagram Based Acne Content

A study in the Journal of the American Academy of Dermatology investigated Instagram’s content on acne and its quality.

Pointers With Dr Portela: How to Fix Dry Skin

In this week’s Pointers with Dr Portela, the 208SkinDoc shares tips on prevention, treatment, and products he recommends for treating dry hands caused by wintery weather.

Employees paying an average of $5,969 annually for family insurance coverage

Since 2011, average family premiums have increased 47%

Johnson & Johnson splitting its consumer health care business into separate company

Separation will allow both entities to respond more quickly to changing markets

Abrocitinib Dosing Effective in Atopic Dermatitis Management

Investigators said that patient-reported outcomes from the 2 abrocitinib groups showed greater efficacy than the dupilumab and placebo groups.

ALA PDT Long-Term Effect on Photoaging

In this study, researchers aim to find the long-term improvements on photoaging after ALA-PDT for AK.

Daylight PDT vs Cryosurgery for AK Prevention

A recent study aimed to examine daylight photodynamic therapy vs cryosurgery for the prevention of actinic keratoses in photodamaged facial skin.

How to Improve AD Patient Education

A study published in Pediatric Dermatology sought to investigate whether an educational handbook could improve atopic dermatitis (AD) symptoms, caregiver confidence in AD management skills, and AD-related quality-of-life.

Is AD associated with Hidradenitis Suppurativa?

A retrospective cohort study published in the International Journal of American Academy of Dermatology investigated the possible association between atopic dermatitis and hidradenitis suppurativa.